14 March 2013 in Journal of Hepato-Biliary-Pancreatic Sciences
1 January 2015 in Journal of Korean Medical Science
Koizumi S, et al. J Korean Med Sci. 2015 Jun;30(6):743-748. http://dx.doi.org/10.3346/jkms.2015.30.6.743
28 June 2011 in Expert Opinion on Pharmacotherapy
Autoimmune pancreatitis (AIP) is a newly developed concept for a peculiar type of pancreatitis, and at present is recognized as a pancreatic lesion reflecting IgG4-related systemic disease. It is of utmost importance to differentiate AIP from pancreatic cancer to avoid unnecessary surgery. The current management strategies for AIP, including its clinical features, diagnostic criteria, clinical subtypes, steroid therapy and prognosis are discussed, based on our 66 AIP cases and papers searched in PubMed from 1992 to March 2011, using the term 'autoimmune pancreatitis'. A new clinicopathological entity, an 'IgG4-related sclerosing disease' is also mentioned. AIP should be considered in the differential diagnosis in elderly male patients presented with obstructive jaundice and pancreatic mass. Steroids are a standard therapy for AIP, but their regimen including maintenance therapy should be evaluated in prospective trials.
25 November 2019 in Clinical Journal of Gastroenterology